Connect
MJA
MJA

Importance of ambulatory blood pressure in hypertension management

Geoffrey A Head, Barry P McGrath, Mark R Nelson and Michael Stowasser
Med J Aust 2013; 198 (1): . || doi: 10.5694/mja12.11516
Published online: 21 January 2013

In reply: The cardiovascular risk associated with white coat hypertension itself is quite separate from the risk of treating white coat hypertension inappropriately.


  • 1 Department of Neuropharmacology, Baker IDI Heart and Diabetes Institute, Melbourne, VIC.
  • 2 Monash University and Southern Health, Melbourne, VIC.
  • 3 University of Tasmania, Hobart, TAS.
  • 4 School of Medicine, University of Queensland, Brisbane, QLD.


Correspondence: geoff.head@baker.edu.au

Acknowledgements: 

This letter has been prepared by members of the Ambulatory Blood Pressure Monitoring Consensus Committee of the National Heart Foundation and the High Blood Pressure Research Council of Australia.

Competing interests:

Relevant disclosures provided in our original article (Med J Aust 2012; 197: 143-144; doi: 10.5694/mja11.11637).

  • 1. Manios ED, Koroboki EA, Tsivgoulis GK, et al. Factors influencing white-coat effect. Am J Hypertens 2008; 21: 153-158.
  • 2. Ejaz AA, Kazory A, Heinig ME. 24-hour blood pressure monitoring in the evaluation of supine hypertension and orthostatic hypotension. J Clin Hypertens (Greenwich) 2007; 9: 952-955.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.